Clobetasol propionate ointment 0.05

This information should not be used to decide whether or not to take clobetasol cream, gel, and ointment or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to clobetasol cream, gel, and ointment. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.

Betamethasone dipropionate was patented by Merck in 1987 as an augmented cream/lotion, Diprolene in the ., and Disprosone in Europe. [7] These patents expired in 2003 and 2007 respectively leading to generic production of betamethasone dipropionate. During this time other topical corticosteroids such as triamcinolone acetonide and clobetasol propionate also became available as generic creams. Merck filed for "pediatric exclusivity" in 2001 launching a clinical trial to prove betamethasone dipropionate's safety and efficacy for use in pediatrics. [8]

Clobetasol propionate ointment 0.05

clobetasol propionate ointment 0.05

Media:

clobetasol propionate ointment 0.05clobetasol propionate ointment 0.05clobetasol propionate ointment 0.05clobetasol propionate ointment 0.05clobetasol propionate ointment 0.05